AnaptysBio, Inc. (ANAB)
43.80
-0.71
(-1.60%)
USD |
NASDAQ |
Dec 09, 16:00
42.20
-1.60
(-3.65%)
After-Hours: 20:00
AnaptysBio Shareholders Equity (Quarterly): -29.42M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ovid Therapeutics, Inc. | 44.70M |
| Ionis Pharmaceuticals, Inc. | 617.97M |
| Vanda Pharmaceuticals, Inc. | 466.00M |
| CorMedix, Inc. | 374.13M |
| Verastem, Inc. | -15.53M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 353.10M |
| Total Liabilities (Quarterly) | 382.51M |
| Debt to Equity Ratio | -11.78 |
| Current Ratio | 8.678 |
| Net Debt Paydown Yield | 0.77% |